Egetis Therapeutics Plans SEK350 Million Share Sale
22 april, 07:46
01:46 AM EDT, 04/22/2026 (MT Newswires) -- Egetis Therapeutics (EGTX.ST) said Tuesday it plans to raise 350 million kronor through an accelerated bookbuilding share offering to Swedish and international institutional investors
The offering is set to close before trading on Wednesday, with the final terms to be disclosed after the book build. Frazier Life Sciences is expected to anchor the offering.
The Swedish pharmaceutical company will use the proceeds primarily to support preparations to commercialize Emcitate in the US in the fourth quarter and to expand its indication, with the remainder for general corporate purposes.
Stifel is the sole global coordinator, while Van Lanschot Kempen and DNB Carnegie are joint bookrunners.
Ämnen i artikeln
Egetis Therapeutics Plans SEK350 Million Share Sale
22 april, 07:46
01:46 AM EDT, 04/22/2026 (MT Newswires) -- Egetis Therapeutics (EGTX.ST) said Tuesday it plans to raise 350 million kronor through an accelerated bookbuilding share offering to Swedish and international institutional investors
The offering is set to close before trading on Wednesday, with the final terms to be disclosed after the book build. Frazier Life Sciences is expected to anchor the offering.
The Swedish pharmaceutical company will use the proceeds primarily to support preparations to commercialize Emcitate in the US in the fourth quarter and to expand its indication, with the remainder for general corporate purposes.
Stifel is the sole global coordinator, while Van Lanschot Kempen and DNB Carnegie are joint bookrunners.
Ämnen i artikeln
Analys
Rapporter
Analys
Rapporter
Marknadsöversikt
1 DAG %
Senast
1 mån
